Pharma Connections Worldwide, Inc.

Pharma Connections Worldwide® is a professional business networking and consulting company focused in the Pharmaceutical, Biotechnology and Life Sciences research industry. Our goal is to facilitate business development opportunities among industry professionals.

Advanced Clinical Concepts

ACC was founded on the belief that the right scientific information delivered in the right way enables prescribers to make better decisions about the brands they use, resulting in improved patient care. To achieve this goal, we apply our marketing, clinical, and scientific expertise toward developing strategic partnerships with clients in the pharmaceutical and biotechnology fields.   At ACC, we put knowledge into practice.

ARSTAT Pharmaceuticals Inc.

Arstat Pharmaceuticals is advancing transformational products that focus on significant unmet needs in women's health. Protected by 11 granted U.S. patents and a European (EPO) patent, the pipeline includes four drug candidates with proven efficacy and safety. Two products are Phase III-ready (confirmed by the FDA), and two other products are ready for Phase IIb. An addressable U.S. market is approximately 50 million women, with projected peak U.S. gross sales exceeding $3.5 billion. This is arguably one of the very best pharmaceutical portfolios in women's health. Arstat's most valuable asset is Nuvocept – the first and only oral contraceptive designed explicitly for overweight and obese women. The FDA has already endorsed an unprecedented clinical program and a potentially unique label. Nuvocept is expected to dominate a multi-billion-dollar segment of the US contraceptive market and address a high public health priority in the post-Roe world. The Company's Founder and acting CEO, Arkady Rubin, Ph.D., with 30 years of industry experience (J&J, Pfizer). Dr. Rubin is a co-inventor of Ortho Tri-Cyclen Lo, the top-selling oral contraceptive in the U.S., with peak sales of over $500M/year. In addition, we are engaged in proprietary R&D activities. We developed and patented two transformational women's health products: NUVOCEPT - the first and only oral contraceptive designed for overweight and obese women (≈60% of 10 million US pill users). Protected by 3 US patents. PREMRING - first-in-class vaginal ring for uterine fibroids and endometriosis (a much-needed solution for >15 million US women). Protected by a US patent. Please visit the company's website (www.arstatinfo.com) for further details.

Simple-Rx

The New Standard For Practice Dispensing

Pitman Pharmacy